Giacobello Scott M. — SEC Form 4 filings
SEC reporting owner CIK 1754154. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-04 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 224,000 shares, $897,207 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 141,600 shares @ $4.13 ($584,808) in Whitehawk Therapeutics, Inc., filed 2026-04-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | CHIEF FINANCIAL OFFICER | 9 | — | 4 legs · 224,000 sh · $897,207 | 17 |
Form 4 filings — Giacobello Scott M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4/A | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 118,476 (derivative) @ $0 · Grant/award (A): 118,476 (derivative) @ $0 | EDGAR |
| 2026-09-15 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 118,476 (derivative) @ $0 · Grant/award (A): 118,476 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 38,265 @ $3.92 | EDGAR |
| 2026-04-17 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Sale (S): 77,000 @ $3.86 · Sale (S): 141,600 @ $4.13 | EDGAR |
| 2026-04-03 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Option exercise (M): 473,902 · Option exercise (M): 473,902 (derivative) @ $0 · Grant/award (A): 300,677 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Option exercise (M): 6,750 · Sale (S): 2,594 @ $3.31 · Option exercise (M): 6,750 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 473,902 (derivative) @ $0 · Grant/award (A): 473,902 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Aadi Bioscience, Inc. (AADI) | Option exercise (M): 6,750 · Sale (S): 2,806 @ $2.35 · Option exercise (M): 6,750 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Aadi Bioscience, Inc. (AADI) | Grant/award (A): 138,263 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0 · Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1754154 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →